Vistagen Therapeutics, Inc.
Balance Sheet
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $30.8M | $67.1M | $119.2M | $16.6M | $68.1M | $103.1M | $1.4M | $13.1M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $46.9M | $82.1M | $120.7M | $17.5M | $71.0M | $104.1M | $1.6M | $13.6M |
| Property, Plant & Equipment | $427.0K | $476.0K | $435.0K | $507.0K | $414.3K | $367.4K | $209.6K | $312.7K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $48.6M | $84.3M | $123.7M | $21.1M | $74.6M | $108.3M | $5.8M | $14.0M |
| Liabilities | ||||||||
| Accounts Payable | $1.5M | $653.0K | $1.5M | $2.5M | $2.8M | $838.3K | $1.8M | $1.1M |
| Total Current Liabilities | $12.8M | $12.6M | $5.1M | $4.6M | $5.8M | $4.2M | $27.7M | $2.8M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $13.0M | $14.0M | $9.4M | $9.0M | $9.9M | $16.3M | $11.5M | $6.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-477.3M | $-407.6M | $-356.2M | $-326.9M | $-267.6M | $-219.8M | $-201.9M | $-181.1M |
| Total Stockholders' Equity | $35.5M | $70.4M | $114.3M | $12.1M | $64.7M | $92.0M | $-5.7M | $7.1M |